These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38127682)

  • 1. Prospective Study of the Multisite Spread of a Medication Safety Intervention: Factors Common to Hospitals With Improved Outcomes.
    Kaplan HC; Goldstein SL; Rubinson C; Daraiseh N; Zhang F; Rodgers IM; Dahale DS; Askenazi DJ; Somers MJG; Zaritsky JJ; Misurac J; Chadha V; Yonekawa KE; Sutherland SM; Weng PL; Walsh KE
    Am J Med Qual; 2024 Jan-Feb 01; 39(1):21-32. PubMed ID: 38127682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of the NINJA (Nephrotoxic Injury Negated by Just-in-Time Action) Program to Identify Nephrotoxicity in Pediatric Patients with Cystic Fibrosis.
    Newton ES; Kurzen EA; Linnemann RW; Shin HS
    J Pediatr Pharmacol Ther; 2021; 26(4):379-383. PubMed ID: 34035683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective multi-center quality improvement initiative (NINJA) indicates a reduction in nephrotoxic acute kidney injury in hospitalized children.
    Goldstein SL; Dahale D; Kirkendall ES; Mottes T; Kaplan H; Muething S; Askenazi DJ; Henderson T; Dill L; Somers MJG; Kerr J; Gilarde J; Zaritsky J; Bica V; Brophy PD; Misurac J; Hackbarth R; Steinke J; Mooney J; Ogrin S; Chadha V; Warady B; Ogden R; Hoebing W; Symons J; Yonekawa K; Menon S; Abrams L; Sutherland S; Weng P; Zhang F; Walsh K
    Kidney Int; 2020 Mar; 97(3):580-588. PubMed ID: 31980139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nephrotoxic Exposures and Acute Kidney Injury in Noncritically Ill Children Stratified by Service.
    Holsteen PE; Gist KM; Brinton JT; Hebert M; Iwanowski M; Kim A; Leath A; Shah A; Soranno DE; Marschner MN
    Hosp Pediatr; 2022 Oct; 12(10):866-877. PubMed ID: 36102129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence-based development of a nephrotoxic medication list to screen for acute kidney injury risk in hospitalized children.
    Goswami E; Ogden RK; Bennett WE; Goldstein SL; Hackbarth R; Somers MJG; Yonekawa K; Misurac J
    Am J Health Syst Pharm; 2019 Oct; 76(22):1869-1874. PubMed ID: 31665764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Healthcare Cost Savings of a Pediatric Nephrotoxic Medication-Associated Acute Kidney Injury Reduction Program in a Simulated Sample.
    Dynan L; Lazear D; Goldstein SL
    J Pharm Pract; 2023 Aug; 36(4):795-802. PubMed ID: 35343287
    [No Abstract]   [Full Text] [Related]  

  • 7. Baby NINJA (Nephrotoxic Injury Negated by Just-in-Time Action): Reduction of Nephrotoxic Medication-Associated Acute Kidney Injury in the Neonatal Intensive Care Unit.
    Stoops C; Stone S; Evans E; Dill L; Henderson T; Griffin R; Goldstein SL; Coghill C; Askenazi DJ
    J Pediatr; 2019 Dec; 215():223-228.e6. PubMed ID: 31761141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and performance of electronic acute kidney injury triggers to identify pediatric patients at risk for nephrotoxic medication-associated harm.
    Kirkendall ES; Spires WL; Mottes TA; Schaffzin JK; Barclay C; Goldstein SL
    Appl Clin Inform; 2014; 5(2):313-33. PubMed ID: 25024752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementation Strategies for Baby NINJA (Nephrotoxic Injury Negated by Just-in-Time Action) to Prevent Neonatal Medication-Induced Kidney Injury.
    Stone SB; Bisaccia E; Zakhary MS; Bashqoy F; Wagner D; Stoops C
    J Pediatr Pharmacol Ther; 2023; 28(4):287-296. PubMed ID: 37795277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A sustained quality improvement program reduces nephrotoxic medication-associated acute kidney injury.
    Goldstein SL; Mottes T; Simpson K; Barclay C; Muething S; Haslam DB; Kirkendall ES
    Kidney Int; 2016 Jul; 90(1):212-21. PubMed ID: 27217196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood transfusion rates in Baby NINJA (Nephrotoxic Injury Negated by Just-in-Time Action)-a single-center experience.
    Gavigan HW; Slagle CL; Krallman KA; Poindexter BB; Hooper DK; Goldstein SL
    Pediatr Nephrol; 2021 Jul; 36(7):1901-1905. PubMed ID: 33479823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary neutrophil gelatinase-associated lipocalin rules out nephrotoxic acute kidney injury in children.
    Goldstein SL; Krallman KA; Schmerge A; Dill L; Gerhardt B; Chodaparavu P; Radomsky A; Kirby C; Askenazi DJ
    Pediatr Nephrol; 2021 Jul; 36(7):1915-1921. PubMed ID: 33459927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction in Nephrotoxic Antimicrobial Exposure Decreases Associated Acute Kidney Injury in Pediatric Hematopoietic Stem Cell Transplant Patients.
    Benoit SW; Goldstein SL; Dahale DS; Haslam DB; Nelson A; Truono K; Davies SM
    Biol Blood Marrow Transplant; 2019 Aug; 25(8):1654-1658. PubMed ID: 31048085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the clinical pharmacist in the prevention of drug-induced acute kidney injury in the intensive care unit.
    Polat EC; Koc A; Demirkan K
    J Clin Pharm Ther; 2022 Dec; 47(12):2287-2294. PubMed ID: 36394173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute kidney injury associated with high nephrotoxic medication exposure leads to chronic kidney disease after 6 months.
    Menon S; Kirkendall ES; Nguyen H; Goldstein SL
    J Pediatr; 2014 Sep; 165(3):522-7.e2. PubMed ID: 24928698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A qualitative dual-site analysis of the pharmacist discharge care (PHARM-DC) intervention using the CFIR framework.
    Murry LT; Keller MS; Pevnick JM; Schnipper JL; Kennelty KA;
    BMC Health Serv Res; 2022 Feb; 22(1):186. PubMed ID: 35151310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of a pharmacist-driven vancomycin monitoring initiative in a community hospital.
    Joseph K; Ramireddy K; Madison G; Turco T; Lui M
    J Clin Pharm Ther; 2021 Aug; 46(4):1103-1108. PubMed ID: 33768555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreases in Nephrotoxic Pain Medications Are Not Associated With Increased Opioid Utilization in Critically Ill Children.
    Stenson EK; DeMasellis G; Shah A; Reiter PD; Brinton J; Martin S; Iwanowski M; Rannie M; Soranno DE; Gist KM
    Pediatr Crit Care Med; 2022 Dec; 23(12):e564-e573. PubMed ID: 36066647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of urine neutrophil gelatinase-associated lipocalin for nephrotoxic medication acute kidney injury screening in neonates.
    Slagle CL; Hemmelgarn T; Gavigan HW; Krallman KA; Goldstein SL
    J Perinatol; 2024 Mar; ():. PubMed ID: 38514742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of early in-hospital medication review by clinical pharmacists on health services utilization.
    Hohl CM; Partovi N; Ghement I; Wickham ME; McGrail K; Reddekopp LN; Sobolev B
    PLoS One; 2017; 12(2):e0170495. PubMed ID: 28192477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.